The eyes have it: FTC probes Valeant over contact lens
October 27, 2015
The Federal Trade Commission is investigating whether Valeant Pharmaceuticals illegally cornered the market for a key component of rigid contact lenses, according to ProPublica. The drug maker disclosed recently that it received a letter from the FTC about an investigation into the purchase of a company that makes lenses, but did not provide further details.
The probe is the latest in a string of investigations into Valeant business practices. Presidential aspirant and Vermont Senator Bernie Sanders began investigating the company over its drug pricing. And federal prosecutors in New York and Massachusetts opened their own probe into patient assistance programs and information given to the US Centers for Medicare & Medicaid Services.
No Comment